Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications PDF

Rating: (23 reviews) Author: Stephen M. Stahl ISBN : 9780521673761 New from $21.83 Format: PDF

Direct download links available PRETITLE Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (Essential Psychopharmacology Series) [Paperback] POSTTITLE from 4shared, mediafire, hotfile, and mirror link

Stahl's Essential Psychopharmacology is intended as a primer text for this field, and can be read cover to cover by anyone from the novice to the expert. Expanded and fully revised, this third edition enlists advances in neurobiology and recent clinical developments to explain with renewed clarity the concepts underlying drug treatment of psychiatric disorders. Features of this edition are clinical advances in antipsychotic and antidepressant therapy. It includes new coverage of sleep disorders, chronic pain, and disorders of impulse control. This remains the essential text for students, scientists, psychiatrists, and other mental health professionals.

Direct download links available for PRETITLE Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications POSTTITLE

• Product Details
• Table of Contents
• Reviews

• Series: Essential Psychopharmacology Series
• Paperback: 1132 pages
• Publisher: Cambridge University Press; 3 edition (March 17, 2008)
• Language: English
• ISBN-10: 0521673763
• ISBN-13: 978-0521673761
• Product Dimensions: 2 x 6.7 x 9.6 inches
• Shipping Weight: 4.8 pounds (View shipping rates and policies)

Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications PDF

The biochemical illustrations are excellent but the text is lacking in nuance. (Maybe that book would require another thousand pages.) The author, in my opinion, is far too keen on a strict medical model and acceptance of DSM IV TR "disorders" and outlier conditions as diseases for which there is a pill lying in wait. The text glosses over these controversies the way that Powerpoint does at a pharma sponsored CME conference.

Nevertheless the chapter on antidepressant augmentation was excellent, though in practice I think it is foolish to use lithium for unipolar depression augmentation because it is the easiest drug to overdose on (and of course one of the big selling points of the SSRIs over TCAs to begin with was the safety factor in a suicide attempt.) One treatment that I was not aware of, and I will definitely start using in refractory cases, is MTHF supplementation which appears very safe and effective. I also learned quite a bit about alpha-2-delta ligands in the excellent chapter on ion channel blockers.

One chapter I had a lot of problems with was sleep disorders. In my opinion, the author is too cavalier about using benzo hypnotics, despite the fact that most evidence based treatment guidelines (i.e ACOEM) specifically warn against this except as a very short-term solution. I am disappointed that he failed to mention that these a history of alcohol or drug dependence changes the whole treatment paradigm. He seems enthusiastic about the "Z" hypnotics despite the scandalous promotion of Ambien as nonaddictive, a claim the manufacturer Aventis was forced to rescind. Not to mention the literature on sleepwalking and sleep driving with this drug (the Patrick Kennedy incident may have been related to this).